SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : SciQuest.com ( SQST ) -- Ignore unavailable to you. Want to Upgrade?

To: Matt Webster who wrote (7)11/23/1999 1:03:00 AM
From: mact  Read Replies (1) | Respond to of 48
 
big difference betw. B2B and B2C...by 2003, B2B will be 1.3 trillion mkt. and B2C 100 billion...barriers to entry and margins also a problem.



To: Matt Webster who wrote (7)12/8/1999 11:45:00 AM
From: hoyasaxa  Read Replies (3) | Respond to of 48
 
Sciquest's business model and customer list is superior to Chemdex. Funded by Oxfordbioscience, they have emerging superstars like Celera (CRA) whose rapid growth should contribute SQST's own already stellar stock price performance.....I think this stock, which has been doing great -- should rocket as biotechnology explodes via the genome product and the health care arena and the internet continue to intermix and mingle.....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News